Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy

OBJECTIVE: Laboratory monitoring is recommended during combination antiretroviral therapy (cART), but the pattern of detected abnormalities and optimal monitoring are unknown. We assessed laboratory abnormalities during initial cART in 2000–2010 across the United States. DESIGN: Observational study...

Full description

Saved in:
Bibliographic Details
Main Authors: Taiwo, Babafemi, Yanik, Elizabeth L., Napravnik, Sonia, Ryscavage, Patrick, Koletar, Susan L., Moore, Richard, Mathews, W. Christopher, Crane, Heidi M., Mayer, Kenneth, Zinski, Anne, Kahn, James S., Eron, Joseph J.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4108282/
https://ncbi.nlm.nih.gov/pubmed/23435300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e3283601115
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items